Pacific Biosciences of California PACB Proceeds from exercises of stock options and other stock issuances
Proceeds from exercises of stock options and other stock issuances at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's proceeds from exercises of stock options and other stock issuances.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's proceeds from exercises of stock options and other stock issuances?
- Pacific Biosciences of California (PACB) reported proceeds from exercises of stock options and other stock issuances of $1.44M in Q1 2026.
- How has Pacific Biosciences of California's proceeds from exercises of stock options and other stock issuances changed year-over-year?
- Pacific Biosciences of California's proceeds from exercises of stock options and other stock issuances decreased by 26.6% year-over-year, from $1.96M to $1.44M.